Literature DB >> 19406133

Evidence for the role of the brain-gut axis in inflammatory bowel disease: depression as cause and effect?

Yvette Taché, Charles N Bernstein.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19406133      PMCID： PMC3675266          DOI： 10.1053/j.gastro.2009.04.032

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  26 in total

Review 1.  Physiology and immunology of the cholinergic antiinflammatory pathway.

Authors:  Kevin J Tracey
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

2.  European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Authors:  R Caprilli; M A Gassull; J C Escher; G Moser; P Munkholm; A Forbes; D W Hommes; H Lochs; E Angelucci; A Cocco; B Vucelic; H Hildebrand; S Kolacek; L Riis; M Lukas; R de Franchis; M Hamilton; G Jantschek; P Michetti; C O'Morain; M M Anwar; J L Freitas; I A Mouzas; F Baert; R Mitchell; C J Hawkey
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

3.  Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys.

Authors:  Esme Fuller-Thomson; Joanne Sulman
Journal:  Inflamm Bowel Dis       Date:  2006-08       Impact factor: 5.325

4.  Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions.

Authors:  Jitender Sareen; Frank Jacobi; Brian J Cox; Shay-Lee Belik; Ian Clara; Murray B Stein
Journal:  Arch Intern Med       Date:  2006-10-23

5.  The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.

Authors:  P Persoons; S Vermeire; K Demyttenaere; B Fischler; J Vandenberghe; L Van Oudenhove; M Pierik; T Hlavaty; G Van Assche; M Noman; P Rutgeerts
Journal:  Aliment Pharmacol Ther       Date:  2005-07-15       Impact factor: 8.171

6.  Depression and anxiety in people with inflammatory bowel disease.

Authors:  L M Kurina; M J Goldacre; D Yeates; L E Gill
Journal:  J Epidemiol Community Health       Date:  2001-10       Impact factor: 3.710

Review 7.  Depression, the autonomic nervous system, and coronary heart disease.

Authors:  Robert M Carney; Kenneth E Freedland; Richard C Veith
Journal:  Psychosom Med       Date:  2005 May-Jun       Impact factor: 4.312

8.  Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study.

Authors:  Christian Mittermaier; Clemens Dejaco; Thomas Waldhoer; Anna Oefferlbauer-Ernst; Wolfgang Miehsler; Markus Beier; Wolfgang Tillinger; Alfred Gangl; Gabriele Moser
Journal:  Psychosom Med       Date:  2004 Jan-Feb       Impact factor: 4.312

9.  The hygiene hypothesis and psychiatric disorders.

Authors:  Graham A W Rook; Christopher A Lowry
Journal:  Trends Immunol       Date:  2008-03-06       Impact factor: 16.687

Review 10.  Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.

Authors:  A C Ford; N J Talley; P S Schoenfeld; E M M Quigley; P Moayyedi
Journal:  Gut       Date:  2008-11-10       Impact factor: 23.059
View more
  14 in total

Review 1.  Gut feelings: the emerging biology of gut-brain communication.

Authors:  Emeran A Mayer
Journal:  Nat Rev Neurosci       Date:  2011-07-13       Impact factor: 34.870

2.  An 18-month study of the effects of IBD symptomatology and emotion regulation on depressed mood.

Authors:  Inês A Trindade; Cláudia Ferreira; Mariana Moura-Ramos; José Pinto-Gouveia
Journal:  Int J Colorectal Dis       Date:  2017-02-09       Impact factor: 2.571

3.  Involvement of central opioid receptors in protective effects of methadone on experimental colitis in rats.

Authors:  Nahid Fakhraei; Nina Javadian; Reza Rahimian; Fatemeh Nili; Nastaran Rahimi; Shiva Hashemizadeh; Ahmad Reza Dehpour
Journal:  Inflammopharmacology       Date:  2018-10-15       Impact factor: 4.473

4.  Cognitive impairment in Crohn's disease is associated with systemic inflammation, symptom burden and sleep disturbance.

Authors:  Daniel R van Langenberg; Greg W Yelland; Stephen R Robinson; Peter R Gibson
Journal:  United European Gastroenterol J       Date:  2016-08-08       Impact factor: 4.623

Review 5.  Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis.

Authors:  Peter Holzer; Florian Reichmann; Aitak Farzi
Journal:  Neuropeptides       Date:  2012-09-11       Impact factor: 3.286

6.  Psychological issues in inflammatory bowel disease: an overview.

Authors:  M S Sajadinejad; K Asgari; H Molavi; M Kalantari; P Adibi
Journal:  Gastroenterol Res Pract       Date:  2012-06-21       Impact factor: 2.260

7.  Role of Corticotropin-releasing Factor Signaling in Stress-related Alterations of Colonic Motility and Hyperalgesia.

Authors:  Yvette Taché; Mulugeta Million
Journal:  J Neurogastroenterol Motil       Date:  2015-01-31       Impact factor: 4.924

8.  Beneficial Effects of Maprotiline in a Murine Model of Colitis in Normal and Reserpinised Depressed Rats.

Authors:  Mohsen Minaiyan; Valiollah Hajhashemi; Mohammad Rabbani; Ehsan Fattahian; Parvin Mahzouni
Journal:  Int Sch Res Notices       Date:  2014-11-13

9.  Correlation between depression, anxiety, and polymorphonuclear cells' resilience in ulcerative colitis: the mediating role of heat shock protein 70.

Authors:  Ilias I Vlachos; Calypso Barbatis; Maria Tsopanomichalou; Lydia Abou-Assabeh; Konstantinos Goumas; Maria Ginieri-Coccossis; Marina Economou; George N Papadimitriou; Efstratios Patsouris; Polyxeni Nicolopoulou-Stamati
Journal:  BMC Gastroenterol       Date:  2014-04-17       Impact factor: 3.067

10.  Effect of venlafaxine on experimental colitis in normal and reserpinised depressed rats.

Authors:  Mohsen Minaiyan; Valiollah Hajhashemi; Mohammad Rabbani; Ehsan Fattahian; Parvin Mahzouni
Journal:  Res Pharm Sci       Date:  2015 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.